Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women
- PMID: 17159088
- DOI: 10.1161/01.HYP.0000252664.24294.ff
Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women
Abstract
Although markers of systemic inflammation may have a role in the development of hypertension, supportive clinical data remain limited. We, therefore, examined interleukin (IL)-6 and C-reactive protein (CRP) in a nested case-control study of 400 women developing hypertension and an equal number of age-matched normotensive control subjects during 10 years of follow-up as part of the Women's Health Study. All of the women initially had nonhypertensive blood pressure values and no history of diagnosis or treatment. Subjects provided self-reported risk factors, and IL-6 and CRP were measured from baseline bloods. Case subjects reported elevated systolic (>or=140 mm Hg) or diastolic (>or=90 mm Hg) blood pressure, newly diagnosed hypertension, or initiating antihypertensive treatment during follow-up. In crude-matched models, IL-6 and CRP quartiles were each strongly associated with hypertension risk (both Ps for trend <0.0001). In multivariate models, the linear trends became nonsignificant, and the relative risks (95% CIs) of hypertension for IL-6 reduced to 1.00 (ref), 1.29 (0.76 to 2.19), 2.14 (1.23 to 3.73), and 1.70 (0.92 to 3.13) and for CRP were 1.00 (ref), 2.09 (1.16 to 3.76), 2.51 (1.42 to 4.44), and 2.44 (1.29 to 4.64), primarily because of confounding by body mass index. Simultaneous adjustment for IL-6 and CRP modestly attenuated both sets of relative risks, although more for IL-6. Finally, there was no effect modification by baseline blood pressure or other risk factors (all Ps for interaction >0.05). Therefore, after multivariate adjustment and strong confounding by body mass index, IL-6 was weakly associated and CRP strongly associated with hypertension risk. In models simultaneously examining IL-6 and CRP, only CRP remained strongly associated with an increased risk of hypertension.
Similar articles
-
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.JAMA. 2001 Jul 18;286(3):327-34. doi: 10.1001/jama.286.3.327. JAMA. 2001. PMID: 11466099 Clinical Trial.
-
Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men.J Am Heart Assoc. 2015 Sep 21;4(9):e001802. doi: 10.1161/JAHA.115.001802. J Am Heart Assoc. 2015. PMID: 26391130 Free PMC article. Clinical Trial.
-
C-reactive protein and the risk of developing hypertension.JAMA. 2003 Dec 10;290(22):2945-51. doi: 10.1001/jama.290.22.2945. JAMA. 2003. PMID: 14665655
-
[Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].Arch Bronconeumol. 2009 Dec;45(12):577-84. doi: 10.1016/j.arbres.2009.05.002. Epub 2009 Jun 23. Arch Bronconeumol. 2009. PMID: 19552994 Spanish.
-
Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.Climacteric. 2005 Dec;8(4):317-26. doi: 10.1080/13697130500345109. Climacteric. 2005. PMID: 16390766 Review.
Cited by
-
Immune and inflammatory mechanisms in hypertension.Nat Rev Cardiol. 2024 Jun;21(6):396-416. doi: 10.1038/s41569-023-00964-1. Epub 2024 Jan 3. Nat Rev Cardiol. 2024. PMID: 38172242 Review.
-
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.Cardiovasc Res. 2021 Nov 22;117(13):2589-2609. doi: 10.1093/cvr/cvab330. Cardiovasc Res. 2021. PMID: 34698811 Free PMC article. Review.
-
The Mechanism of Acupuncture in Treating Essential Hypertension: A Narrative Review.Int J Hypertens. 2019 Mar 7;2019:8676490. doi: 10.1155/2019/8676490. eCollection 2019. Int J Hypertens. 2019. PMID: 30984420 Free PMC article. Review.
-
CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.Hum Genomics. 2012 Aug 2;6(1):9. doi: 10.1186/1479-7364-6-9. Hum Genomics. 2012. PMID: 23245743 Free PMC article.
-
Tooth Loss and Metabolic Syndrome in South Korea: The 2012 Korean National Health and Nutrition Examination Survey.Medicine (Baltimore). 2016 Apr;95(16):e3331. doi: 10.1097/MD.0000000000003331. Medicine (Baltimore). 2016. PMID: 27100416 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous